Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alk-UA: Sodium Bicarbonate for Urine Alkalinization in Type 1 Diabetes
NCT02502071Phase 4Completed
- Sponsor
- University of Colorado Denver
- Start
- Jan 2017
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of sodium bicarbonate in diabetic nephropathy (DN), sponsored by University of Colorado Denver. Primary endpoints: Change in Urine Uric Acid Concentration at Day 2 and Change in Number of Participants With Urine Uric Acid Precipitation at Day 2. Started Jan 2017; status: completed.
02
Drugs
sodium bicarbonate
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT02502071.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02502071.